- Home
- PNC vs BMY Comparison
PNC vs BMY Comparison
Compare PNC & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PNC | BMY |
|---|---|---|
| Founded | 1852 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.9B | 110.2B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PNC | BMY |
|---|---|---|
| Price | $221.28 | $54.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 14 |
| Target Price | ★ $221.26 | $57.64 |
| AVG Volume (30 Days) | 2.2M | ★ 14.2M |
| Earning Date | 01-16-2026 | 02-05-2026 |
| Dividend Yield | 3.05% | ★ 4.56% |
| EPS Growth | ★ 20.86 | N/A |
| EPS | ★ 16.61 | 2.97 |
| Revenue | $22,320,000,000.00 | ★ $48,034,000,000.00 |
| Revenue This Year | $13.22 | $0.28 |
| Revenue Next Year | $4.86 | N/A |
| P/E Ratio | ★ $13.44 | $18.60 |
| Revenue Growth | ★ 7.48 | 1.26 |
| 52 Week Low | $145.12 | $42.52 |
| 52 Week High | $227.00 | $63.33 |
Technical Indicators
Market Signals| Indicator | PNC | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 65.91 | 50.76 |
| Support Level | $209.53 | $55.51 |
| Resistance Level | $227.00 | $57.04 |
| Average True Range (ATR) | 4.30 | 1.12 |
| MACD | -0.12 | -0.23 |
| Stochastic Oscillator | 70.47 | 43.47 |
Price Performance
Historical ComparisonAbout PNC PNC Financial Services Group Inc. (The)
PNC Financial is one of the three super-regional banks in the US, with around $560 billion in total assets at the end of June 30, 2025. Headquartered in Pittsburgh, Pennsylvania, PNC Financial has a coast-to-coast branch network, with a strong presence in the US Midwest and Northeast. It is currently expanding in the Southern and Western regions of the US. The bank provides a diversified set of financial services in retail banking, commercial banking, card and treasury management, asset management, and investment banking. PNC derived around 37% of revenue from fee income and 63% from net interest income in 2024.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.